Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada
MONTREAL and BOCA RATON, Fla., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”) and TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD”) announced today that Knight's New Drug Submission (NDS) for Joyesta™ has been …